Moderna Inc (MRNA)
Debt-to-equity ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 13,854,000 | 19,123,000 | 14,145,000 | 2,561,000 | 1,175,000 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $13,854,000K
= 0.00
Moderna Inc's debt-to-equity ratio has shown a generally stable trend over the past five years, ranging from 0.03 to 0.06. The ratio indicates that the company has maintained a conservative capital structure during this period, with a low level of debt relative to its equity. Specifically, the ratio has ranged from 0.03 to 0.06, indicating that, on average, for every dollar of equity, the company has carried between 3 to 6 cents of debt. This suggests that Moderna Inc relies more on equity financing rather than debt to support its operations and investments. Overall, the consistent low debt-to-equity ratio reflects a prudent approach by Moderna Inc in managing its financial leverage and maintaining financial stability.
Peer comparison
Dec 31, 2023